I started serious Investing Journey in Jan 2000 to create wealth through long-term investing and short-term trading; but as from April 2013 my Journey in Investing has changed to create Retirement Income for Life till 85 years old in 2041 for two persons over market cycles of Bull and Bear.

Since 2017 after retiring from full-time job as employee; I am moving towards Investing Nirvana - Freehold Investment Income for Life investing strategy where 100% of investment income from portfolio investment is cashed out to support household expenses i.e. not a single cent of re-investing!

It is 57% (2017 to Aug 2022) to the Land of Investing Nirvana - Freehold Income for Life!

Click to email CW8888 or Email ID : jacobng1@gmail.com



Welcome to Ministry of Wealth!

This blog is authored by an old multi-bagger blue chips stock picker uncle from HDB heartland!

"The market is not your mother. It consists of tough men and women who look for ways to take money away from you instead of pouring milk into your mouth." - Dr. Alexander Elder

"For the things we have to learn before we can do them, we learn by doing them." - Aristotle

It is here where I share with you how I did it! FREE Education in stock market wisdom.

Think Investing as Tug of War - Read more? Click and scroll down



Important Notice and Attention: If you are looking for such ideas; here is the wrong blog to visit.

Value Investing
Dividend/Income Investing
Technical Analysis and Charting
Stock Tips

Monday 20 May 2013

Biosensors Receives CE Mark Approval for BioMatrix NeoFlex™

 
0 May 2013 10:24 Biosensors International Group, Ltd. has announced CE Mark approval for BioMatrix NeoFlex, the latest addition to the BioMatrix family of drug-eluting stents. BioMatrix NeoFlex features a new advanced stent delivery system, improving pushability, trackability and crossability.
 
It also has a lower lesion entry profile than its predecessor. BioMatrix NeoFlex retains the same unique combination of abluminal biodegradable polymer coating, proprietary limus drug Biolimus A9 and flexible platform which has made the BioMatrix stent family an increasingly popular choice of DES in the global markets where it is available...
 
 
Posted by Createwealth8888 at 11:50
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)
Related Posts with Thumbnails